|
PKN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.928400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.246800E-01 |
| Normal-vs-Stage2 |
4.243600E-01 |
| Normal-vs-Stage3 |
3.840500E-03 |
| Normal-vs-Stage4 |
5.94520000000154E-05 |
| Stage1-vs-Stage2 |
9.648800E-01 |
| Stage1-vs-Stage3 |
3.162300E-02 |
| Stage1-vs-Stage4 |
3.772500E-04 |
| Stage2-vs-Stage3 |
2.711800E-01 |
| Stage2-vs-Stage4 |
7.701800E-02 |
| Stage3-vs-Stage4 |
2.415800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.492500E-02 |
| Normal-vs-AfricanAmerican |
7.809200E-04 |
| Normal-vs-Asian |
6.232400E-01 |
| Caucasian-vs-AfricanAmerican |
3.200400E-02 |
| Caucasian-vs-Asian |
2.663200E-01 |
| AfricanAmerican-vs-Asian |
2.553800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.799900E-03 |
| Normal-vs-Female |
3.278000E-01 |
| Male-vs-Female |
1.873720E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.634400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.137770E-01 |
| Normal-vs-Age(61-80Yrs) |
7.462800E-03 |
| Normal-vs-Age(81-100Yrs) |
4.187600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.893800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.937200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.016200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.033600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.713400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.999200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.474440E-01 |
| Normal-vs-Grade 2 |
9.009200E-01 |
| Normal-vs-Grade 3 |
2.788800E-04 |
| Normal-vs-Grade 4 |
1.73580000373263E-08 |
| Grade 1-vs-Grade 2 |
2.580200E-01 |
| Grade 1-vs-Grade 3 |
7.96950000000463E-05 |
| Grade 1-vs-Grade 4 |
1.36130000050194E-07 |
| Grade 2-vs-Grade 3 |
2.31459999999739E-05 |
| Grade 2-vs-Grade 4 |
1.95489957555139E-10 |
| Grade 3-vs-Grade 4 |
7.998300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.149400E-01 |
| Normal-vs-ccB subtype |
1.444890E-04 |
| ccA subtype-vs-ccB subtype |
2.5506999956626E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.834100E-02 |
| Normal-vs-N1 |
6.656700E-03 |
| N0-vs-N1 |
1.151550E-01 |
|
|
